Tag: immunohematology market analysis

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Current and Projected Market Size of the Immunohematology Industry?

The size of the immunohematology market has consistently expanded in the past few years. The market value is forecasted to surge from $2.46 billion in 2024 to $2.55 billion in 2025, representing a compound annual growth rate (CAGR) of 3.6%. The positive growth observed in the historical period is linked to developments in blood transfusion technology, the incidence of blood-related disorders, the broadening scope of blood banks, governmental initiatives promoting blood safety, a rise in surgical procedures, and an increased understanding of risks associated with transfusion.

The market for immunohematology is projected to exhibit robust growth in the coming years. The market’s size is expected to expand to “$3.17 billion by 2029 with a compound annual growth rate (CAGR) of 5.7%. The predicted growth during the forecast period is due to factors such as the growing need for point-of-care testing, the introduction of new blood products, enhancement in healthcare infrastructure, blood compatibility genetic testing, and regulatory backing for blood safety. Key trends during the forecast period will include automated and high-output systems, modern blood typing techniques, methods for antibody detection, patient blood management initiatives, and the application of artificial intelligence in analysis, as well as the integration of telemedicine.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10295&type=smp

#Which Factors Are Currently Driving The Growth Of The Immunohematology Market?

Increasing incidences of hematological disorders are anticipated to fuel the expansion of the immunohematology market in the future. Hematological disorders represent a wide array of conditions impacting the blood and its components, such as red cells, white cells, platelets, and plasma. Immunohematology plays a crucial role in carrying out secure and effective blood transfusions, as it helps avert transfusion reactions instigated by incompatible blood types or the existence of antibodies in the recipient’s blood. Techniques used in immunohematology are also utilized to diagnose and treat diseases linked to the immune system which could influence the hematological system. For example, according to Cancer Research UK, a research organization based in the UK, it’s expected that the average number of new leukemia cases arising from hematological disorders in the UK will rise from approximately 12,400 cases in 2023-2025 to roughly 14,500 cases in 2038-2040. Therefore, the increasing incidence rate of hematological disorders is propelling the expansion of the immunohematology market.

The immunohematology market covered in this report is segmented –

1) By Product: Analyzers And Systems, Reagents

2) By Technology: Biochips, Erythrocyte-Magnetized Technology (Met), Gel Cards, Microplates, Polymerase Chain Reaction (PCR)

3) By Disease: Blood-Related Diseases, HIV, Hepatitis

4) By Application: Pretransfusion Testing, Investigation Of Immune Hemolysis, Perinatal Testing, Blood Group Phenotyping, Leucocyte And Platelet Serology

5) By End User: Blood Banks, Diagnostic And Reference Laboratories, Hospitals, Academic And Research Institutes

Subsegments:

1) By Analyzers And Systems: Blood Typing Analyzers, Cross-Matching Analyzers, Gel Card Systems

2) By Reagents: Blood Grouping Reagents, Antisera, Control Serum

What Long-Term Trends Are Likely To Affect The Immunohematology Market?

Many of the leading players in the immunohematology market are zeroing in on the creation of cutting-edge diagnostic tools, such as soluble recombinant proteins, which are geared towards offsetting the disruptive effects of daratumumab, a cancer treatment strategy. Soluble recombinant proteins, generated through the application of recombinant DNA methodology, hold their structures and functionality in a soluble form in host cells or solutions, making them beneficial for therapeutic and research purposes. For illustration, Grifols, S.A., a pharmaceutical entity based in Spain, introduced Grifols sCD38, a novel soluble recombinant protein-based solution in November 2023. Constructed to manage the disruptions daratumumab causes on important transfusion compatibility tests, Grifols’sCD38 is a pioneering solution that stops daratumumab from sticking to CD38 proteins on red blood cells, guaranteeing precise pre-transfusion test outcomes. Tailored explicitly for multiple myeloma patients, this solution boosts transfusion protocols and lessens the chances of delay in administering urgent transfusions, by ensuring a more streamlined procedure for crossmatching, identification, and screening.

Who Are The Main Participants Shaping The Immunohematology Market Landscape?

Major companies operating in the immunohematology market include Ortho Clinical Diagnostics Inc., Immunocor Inc., Abbott Laboratories, Siemens Healthineers AG, Grifols S.A., Beckman Coulter Inc., Thermo Fisher Scientific Inc., Becton Dickinson and Company, Merck Co. & KGaA, Bio-Rad Laboratories, Sysmex Corporation, Danaher Corporation, Biosystems S.A., Roche Holdings AG, Mindray Medical International Limited, F.Hoffmann La-Roche Ltd., Biotest AG, Cardinal Health Inc., Quotient Limited, DiaSorin S.p.A., Lorne Laboratories Ltd., Biokit S.A., Avox Technologies, Diagnostic Automation/Cortez Diagnostics Inc., Inno-train Diagnostik GmbH, Drucker Diagnostics Inc., Immundia Diagnostics Pvt. Ltd.

https://www.thebusinessresearchcompany.com/report/immunohematology-global-market-report

Which Region Currently Holds The Largest Share In The Immunohematology Market?

North America was the largest region in the immunohematology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global immunohematology market during the forecast period. The regions covered in the immunohematology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=10295&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Does the Forecast Indicate for the Immunohematology Market From 2025 to 2029?

In recent times, the immunohematology market has demonstrated consistent growth. The market value is anticipated to rise from $2.46 billion in 2024 to $2.55 billion in 2025, corresponding to a compound annual growth rate (CAGR) of 3.6%. Factors contributing to growth during the historical period include advancements in blood transfusion technologies, the widespread occurrence of blood disorders, the proliferation of blood banks, government efforts towards ensuring blood safety, a rise in surgical procedures, and a heightened awareness about risks related to transfusion.

In the coming years, expect to see a robust expansion in the immunohematology market. It’s predicted to reach $3.17 billion by 2029, boasting a compound annual growth rate (CAGR) of 5.7%. This projected growth during the forecasted period is linked to the rising popularity of point-of-care testing, the emergence of innovative blood products, the development of healthcare infrastructures, the utilization of genetic testing for blood compatibility, and regulatory assistance for blood safety. Key trends for this forecasted span include automation and high-throughput systems, advances in molecular blood typing methods, techniques for antibody detection, the implementation of patient blood management programs, as well as the incorporation of AI in analysis and telemedicine.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10295&type=smp

What Elements Are Contributing To Growth In The Immunohematology Market?

The increase in the occurrence rate of blood disorders is projected to steer the escalation of the immunohematology market in the future. Blood disorders are a varied group of ailments that influence blood and its components like red blood cells, white blood cells, platelets, and plasma. Immunohematology plays a critical role in safeguarding effective and safe blood transfusions, as it aids in avoiding transfusion reactions resulting from mismatched blood types or the existence of antibodies in the recipient’s blood. Techniques in immunohematology are employed in diagnosing and treating ailments related to the immune system that could potentially affect the blood system. For instance, Cancer Research UK, a research organization based in the UK, anticipates the mean rate of new leukemia cases due to blood disorders in the UK to ascend from nearly 12,400 cases in 2023-2025 to approximately 14,500 cases in 2038-2040. Hence, the increasing occurrence rate of blood disorders is stimulating the expansion of the immunohematology market.

Which Segments Are Detailed In The Global Immunohematology Market Report?

The immunohematology market covered in this report is segmented –

1) By Product: Analyzers And Systems, Reagents

2) By Technology: Biochips, Erythrocyte-Magnetized Technology (Met), Gel Cards, Microplates, Polymerase Chain Reaction (PCR)

3) By Disease: Blood-Related Diseases, HIV, Hepatitis

4) By Application: Pretransfusion Testing, Investigation Of Immune Hemolysis, Perinatal Testing, Blood Group Phenotyping, Leucocyte And Platelet Serology

5) By End User: Blood Banks, Diagnostic And Reference Laboratories, Hospitals, Academic And Research Institutes

Subsegments:

1) By Analyzers And Systems: Blood Typing Analyzers, Cross-Matching Analyzers, Gel Card Systems

2) By Reagents: Blood Grouping Reagents, Antisera, Control Serum

Which Emerging Trends And Strategic Shifts Are Shaping The Immunohematology Market?

Leading firms in the immunohematology market, such as Grifols, S.A., are making strides in the creation and implementation of advanced diagnostic techniques like soluble recombinant proteins that tackle the challenges posed by cancer therapy drug daratumumab. Soluble recombinant proteins are engineered via recombinant DNA methodologies to remain stable and effective in a host cell or solution, making them suitable for research and treatment purposes. Back in November 2023, Grifols, based in Spain, introduced Grifols sCD38 solution, the first of its kind soluble recombinant protein. It was specifically devised to mitigate the complications that daratumumab causes in essential blood transfusion compatibility examinations. The solution, tailor-made for individuals with multiple myeloma, stops daratumumab from coupling with CD38 proteins on red blood cells thus leading to more accurate pre-transfusion result. Grifols sCD38 boosts blood transfusion processes and reduces time lags in provision of paramount transfusions by streamlining the entire procedure, including screening, identification, and crossmatching.

Who Are The Key Contributors To Growth In The Immunohematology Market?

Major companies operating in the immunohematology market include Ortho Clinical Diagnostics Inc., Immunocor Inc., Abbott Laboratories, Siemens Healthineers AG, Grifols S.A., Beckman Coulter Inc., Thermo Fisher Scientific Inc., Becton Dickinson and Company, Merck Co. & KGaA, Bio-Rad Laboratories, Sysmex Corporation, Danaher Corporation, Biosystems S.A., Roche Holdings AG, Mindray Medical International Limited, F.Hoffmann La-Roche Ltd., Biotest AG, Cardinal Health Inc., Quotient Limited, DiaSorin S.p.A., Lorne Laboratories Ltd., Biokit S.A., Avox Technologies, Diagnostic Automation/Cortez Diagnostics Inc., Inno-train Diagnostik GmbH, Drucker Diagnostics Inc., Immundia Diagnostics Pvt. Ltd.

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/immunohematology-global-market-report

Which Region Is Projected To Lead The Immunohematology Market By 2025?

North America was the largest region in the immunohematology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global immunohematology market during the forecast period. The regions covered in the immunohematology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=10295&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Growth Rate of the Immunohematology Market?

In recent times, the immunohematology market has seen consistent growth. It’s projected to rise from $2.46 billion in 2024 to $2.57 billion in 2025, marking a compound annual growth rate (CAGR) of 4.6%. The increase during the historic period is largely due to improvements in blood transfusion technology, commonality of blood ailments, enlargement of blood bank facilities, government efforts for blood safety, a surge in surgical procedures, and heightened knowledge regarding the hazards associated with transfusions.

What Growth Rate Is Forecasted for the Immunohematology Market by 2029?

The size of the immunohematology market is projected to experience significant expansion in the upcoming years, with predictions reaching “$3.24 billion by 2029, reflecting a compound annual growth rate (CAGR) of 5.9%. This predicted rise during the forecast term can be linked to factors such as the growing need for point-of-care testing, the introduction of innovative blood products, the development of healthcare infrastructure, genetic tests for blood compatibility, and regulatory backing for blood safety. Major trends expected during this projection period encompass automation, high-throughput systems, methodologies for molecular blood typing, techniques for antibody detection, patient blood management schemes, AI incorporation in analytical processes, and the integration of telemedicine.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10295&type=smp

Which Key Companies Are Shaping the Future of the Immunohematology Market?

Major companies operating in the immunohematology market include Ortho Clinical Diagnostics Inc., Immunocor Inc., Abbott Laboratories, Siemens Healthineers AG, Grifols S.A., Beckman Coulter Inc., Thermo Fisher Scientific Inc., Becton Dickinson and Company, Merck Co. & KGaA, Bio-Rad Laboratories, Sysmex Corporation, Danaher Corporation, Biosystems S.A., Roche Holdings AG, Mindray Medical International Limited, F.Hoffmann La-Roche Ltd., Biotest AG, Cardinal Health Inc., Quotient Limited, DiaSorin S.p.A., Lorne Laboratories Ltd., Biokit S.A., Avox Technologies, Diagnostic Automation/Cortez Diagnostics Inc., Inno-train Diagnostik GmbH, Drucker Diagnostics Inc., Immundia Diagnostics Pvt. Ltd.

Which Factors Are Driving Demand in the Immunohematology Industry?

The immunohematology market’s expansion is anticipated to be driven by the increasing incidence rate of hematological conditions. These disorders, which affect blood and its components such as red and white blood cells, platelets, and plasma, are varied. Immunohematology is critical for effective and safe blood transfusions as it aids in avoiding transfusion reactions due to mismatched blood types or antibodies in the recipient’s blood. Techniques in immunohematology are also utilized in diagnosing and treating diseases associated with the immune system that may affect the hematological system. As an example, Cancer Research UK, a research institution based in the UK, estimates that the number of new leukemia cases rising from hematological disorders is expected to increase from about 12,400 cases in 2023-2025 to nearly 14,500 cases in 2038-2040 in the UK. Consequently, the growth of the immunohematology market is being propelled by the increasing incidence rate of hematological conditions.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=10295&type=smp

How Is the Immunohematology Market Segmented by Several Divisions?

The immunohematology market covered in this report is segmented –

1) By Product: Analyzers And Systems, Reagents

2) By Technology: Biochips, Erythrocyte-Magnetized Technology (Met), Gel Cards, Microplates, Polymerase Chain Reaction (PCR)

3) By Disease: Blood-Related Diseases, HIV, Hepatitis

4) By Application: Pretransfusion Testing, Investigation Of Immune Hemolysis, Perinatal Testing, Blood Group Phenotyping, Leucocyte And Platelet Serology

5) By End User: Blood Banks, Diagnostic And Reference Laboratories, Hospitals, Academic And Research Institutes

Subsegments:

1) By Analyzers And Systems: Blood Typing Analyzers, Cross-Matching Analyzers, Gel Card Systems

2) By Reagents: Blood Grouping Reagents, Antisera, Control Serum

What are the Emerging Market Trends Driving the Growth of the Immunohematology Industry?

Key players in the immunohematology market are concentrating on the creation of pioneering diagnostic tools, specifically soluble recombinant proteins created to counteract the disruption caused by the cancer treatment daratumumab. Soluble recombinant protein, made with recombinant DNA technology and maintains its function in a host cell or solution, makes it suitable for both research and clinical applications. For example, in November 2023, the Spain-based pharmaceutical firm, Grifols, S.A., introduced the Grifols sCD38 solution. This was the first soluble recombinant protein to be developed and was aimed at addressing the issues caused by daratumumab cancer treatment during critical blood transfusion compatibility assessments. It was particularly devised for patients with multiple myeloma. This revolutionary solution prevents daratumumab from bonding with CD38 proteins on red blood cells, providing accurate results for pre-transfusion tests. By enabling more efficient procedures for screening, identifying, and crossmatching, the Grifols sCD38 solution optimizes blood transfusion processes and reduces delays in providing crucial transfusions.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/immunohematology-global-market-report

Which Regions Are Driving Growth in the Immunohematology Market?

North America was the largest region in the immunohematology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global immunohematology market during the forecast period. The regions covered in the immunohematology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10295

This Report Delivers Insight On:

1. How big is the immunohematology market, and how is it changing globally?

2. Who are the major companies in the immunohematology market, and how are they performing?

3. What are the key opportunities and risks in the immunohematology market right now?

4. Which products or customer segments are growing the most in the immunohematology market?

5. What factors are helping or slowing down the growth of the immunohematology market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the immunohematology industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

#How Has the Immunohematology Market Growth Performance Trended Historically, And What Lies Ahead?#_x000D_

In the past few years, the size of the immunohematology market has seen a consistent increase. It is expected to expand from $2.46 billion in 2024 to $2.57 billion in 2025, experiencing a compound annual growth rate (CAGR) of 4.6%. This growth during the historical period can be associated with the progress in blood transfusion technology, the rising occurrence of blood ailments, enlargement of blood banks, government-led initiatives for ensuring the safety of blood, the surge in surgical procedures, and heightened awareness about the hazards related to transfusions._x000D_

_x000D_

Expectations are high for significant expansion in the immunohematology market in the upcoming years. The projected size of the market is anticipated to reach “$3.24 billion by 2029, witnessing a compound annual growth rate (CAGR) of 5.9%. This anticipated growth over the forecast period can be ascribed to various factors such as the rising demand for point-of-care testing, emergence of new blood products, development of healthcare infrastructure, genetic testing for determining blood compatibility, and stringent regulation for ensuring blood safety. The forecast period is likely to see major trends like the incorporation of automation and high-throughput systems, use of molecular blood typing methods, advent of antibody detection techniques, prioritization of patient blood management programs, and the integration of artificial intelligence in analysis along with telemedicine._x000D_

_x000D_

#Download a free sample to assess the report’s scope and structure:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=10295&type=smp_x000D_

_x000D_

#What External and Internal Drivers Are Contributing to the Growth of theImmunohematology Market?#_x000D_

The anticipated increase in hematological disorders is predicted to stimulate the expansion of the immunohematology market in the future. These are varying conditions that influence the blood and its components such as red blood cells, white blood cells, plasma, and platelets. Immunohematology plays a crucial role in ensuring blood transfusions are safe and effective by preventing reactions that may occur due to incompatible blood types or the presence of antibodies in the recipient’s blood. It also employs techniques for diagnosing and treating diseases related to the immune system which might affect the system of blood. For example, Cancer Research UK, a research organization based in the UK, has projected that the average number of new cases of leukemia triggered by hematological disorders will rise from an estimated 12,400 cases in 2023-2025 to approximately 14,500 cases in 2038-2040. Consequently, the rising rate of hematological disorders’ prevalence is fueling the growth of the immunohematology market._x000D_

_x000D_

#What Segment Types Define the Immunohematology Market Structure?#_x000D_

The immunohematology market covered in this report is segmented –_x000D_

_x000D_

1) By Product: Analyzers And Systems, Reagents_x000D_

2) By Technology: Biochips, Erythrocyte-Magnetized Technology (Met), Gel Cards, Microplates, Polymerase Chain Reaction (PCR)_x000D_

3) By Disease: Blood-Related Diseases, HIV, Hepatitis_x000D_

4) By Application: Pretransfusion Testing, Investigation Of Immune Hemolysis, Perinatal Testing, Blood Group Phenotyping, Leucocyte And Platelet Serology_x000D_

5) By End User: Blood Banks, Diagnostic And Reference Laboratories, Hospitals, Academic And Research Institutes_x000D_

_x000D_

Subsegments:_x000D_

1) By Analyzers And Systems: Blood Typing Analyzers, Cross-Matching Analyzers, Gel Card Systems_x000D_

2) By Reagents: Blood Grouping Reagents, Antisera, Control Serum_x000D_

_x000D_

#Request customized data on this market:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=10295&type=smp_x000D_

_x000D_

#Which Geographic Areas Hold the Strongest Growth Potential in the Immunohematology Market?#_x000D_

North America was the largest region in the immunohematology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global immunohematology market during the forecast period. The regions covered in the immunohematology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa_x000D_

_x000D_

#What Long-Term Trends Are Transforming the Competitive Landscape of the Immunohematology Market?#_x000D_

Leading businesses in the immunohematology field are concentrating on creating innovative diagnostic aids such as soluble recombinant proteins, developed to counteract the disturbance caused by the cancer treatment daratumumab. These proteins, manufactured via recombinant DNA technology, remain functional and correctly folded in a soluble format in a host cell or liquid, assisting their use in research and medical settings. Grifols, S.A., a pharmaceutical firm based in Spain, for instance, in November 2023, unveiled the Grifols sCD38 solution. This is the inaugural soluble recombinant protein produced by Grifols, designed to deal with the interference created by the daratumumab cancer therapy during crucial blood transfusion compatibility testing. It is specifically created for multiple myeloma patients, this revolutionary solution prevents daratumumab from adhering to CD38 proteins on red blood cells, ensuring accurate pre-transfusion test results. The Grifols sCD38 improves blood transfusion procedures and reduces delays in supplying crucial transfusions by allowing a more streamlined process for screening, identifying, and cross-matching._x000D_

_x000D_

#View the full report here:#_x000D_

https://www.thebusinessresearchcompany.com/report/immunohematology-global-market-report_x000D_

_x000D_

#What Is the Definition of the Immunohematology Market?#_x000D_

Immunohematology is a branch of laboratory medicine that studies blood groups and the body’s immune response to foreign substances, particularly in blood transfusions. Immune hematological techniques are used to locate and address diagnostic issues in patients with hematological conditions, such as auto-immune hemolytic anemia._x000D_

_x000D_

#Purchase the full report and get a swift delivery:#_x000D_

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10295_x000D_

_x000D_

#About The Business Research Company:#_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 3156230293_x000D_

Asia +44 2071930708_x000D_

Europe +44 2071930708_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What External and Internal Drivers Are Contributing to the Growth of theImmunohematology Market?

The increase in hematological disease incidence is predicted to stimulate the expansion of the immunohematology market. Hematological disorders, which affect blood and its components such as red and white blood cells, platelets, and plasma, feature a wide range of conditions. Essential for successful and safe blood transfusions, immunohematology aids in averting transfusion reactions triggered by mismatched blood types or recipient antibodies. Additionally, immunohematology methods diagnose and treat diseases connected to the immune system that potentially influence the hematological system. For example, Cancer Research UK, a British research institution, anticipates the average leukemia cases caused by hematological disorders to increase from roughly 12,400 cases in 2023-2025 to approximately 14,500 cases in 2038-2040 in the UK. Consequently, the surge in hematological disorder incidence is fuelling the immunohematology market’s growth.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10295&type=smp

#How Does the ProjectedImmunohematology Market Growth Compare Over the Forecast Period?

Over recent years, the immunohematology market’s size has seen a consistent increase. Projected growth indicates an increase from $2.46 billion in 2024 to $2.57 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 4.6%. This historical growth trajectory has been propelled by factors including advancements in blood transfusion science, the commonality of blood disorders, the growth of blood banks, government measures ensuring blood safety, a rise in surgical procedures, and heightened awareness about the risks associated with transfusions.

The immunohematology market is set to experience notable expansion in the coming years, predicted to reach $3.24 billion in 2029, with a compound annual growth rate (CAGR) of 5.9%. This projected growth within the forecast period can be traced back to factors such as the growing need for point-of-care testing, the introduction of new blood products, enhancement of healthcare infrastructure, the application of genetic testing in determining blood compatibility, and regulatory policies promoting blood safety. Key trends for this forecast period are the adoption of automation and high-throughput systems, advancements in molecular blood typing procedures, improved antibody detection methods, the implementation of patient blood management programs, and the incorporation of artificial intelligence in analysis and telemedicine.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10295

Which Upcoming Market Trends and Innovations Are Set to Influence theImmunohematology Market’s Path Forward?

Top-tier firms in the immunohematology sector are honing in on innovating diagnostic solutions, such as soluble recombinant proteins, to counteract the interference from the cancer treatment daratumumab. Soluble recombinant proteins are proteins synthesized via recombinant DNA technology, which remain correctly folded and functional in a host cell or solution, making them versatile in research and therapeutic applications. For example, in November 2023, Grifols, S.A., a pharmaceutical corporation based in Spain, introduced the Grifols sCD38 solution. Grifols’ sCD38 stands as the pioneering soluble recombinant protein. This solution was devised to tackle the obstructions posed by daratumumab during critical blood transfusion compatibility tests. Tailored specifically for patients with multiple myeloma, this innovative solution prevents daratumumab from binding to CD38 proteins on the surface of red blood cells, thereby assuring accurate pre-transfusion test results. By streamlining the screening, identification, and crossmatching processes, Grifols sCD38 improves blood transfusion procedures and reduces potential delays in crucial transfusion provision.

Who Are the Dominant Market Players Pushing the Boundaries of theImmunohematology Market?

Major companies operating in the immunohematology market include Ortho Clinical Diagnostics Inc., Immunocor Inc., Abbott Laboratories, Siemens Healthineers AG, Grifols S.A., Beckman Coulter Inc., Thermo Fisher Scientific Inc., Becton Dickinson and Company, Merck Co. & KGaA, Bio-Rad Laboratories, Sysmex Corporation, Danaher Corporation, Biosystems S.A., Roche Holdings AG, Mindray Medical International Limited, F.Hoffmann La-Roche Ltd., Biotest AG, Cardinal Health Inc., Quotient Limited, DiaSorin S.p.A., Lorne Laboratories Ltd., Biokit S.A., Avox Technologies, Diagnostic Automation/Cortez Diagnostics Inc., Inno-train Diagnostik GmbH, Drucker Diagnostics Inc., Immundia Diagnostics Pvt. Ltd.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/immunohematology-global-market-report

#thebusinessresearchcompany #marketresearch #marketintelligence

The immunohematology market covered in this report is segmented –

1) By Product: Analyzers And Systems, Reagents

2) By Technology: Biochips, Erythrocyte-Magnetized Technology (Met), Gel Cards, Microplates, Polymerase Chain Reaction (PCR)

3) By Disease: Blood-Related Diseases, HIV, Hepatitis

4) By Application: Pretransfusion Testing, Investigation Of Immune Hemolysis, Perinatal Testing, Blood Group Phenotyping, Leucocyte And Platelet Serology

5) By End User: Blood Banks, Diagnostic And Reference Laboratories, Hospitals, Academic And Research Institutes

Subsegments:

1) By Analyzers And Systems: Blood Typing Analyzers, Cross-Matching Analyzers, Gel Card Systems

2) By Reagents: Blood Grouping Reagents, Antisera, Control Serum

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=10295&type=smp

What Regions Are Dominating the Immunohematology Market Growth?

North America was the largest region in the immunohematology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global immunohematology market during the forecast period. The regions covered in the immunohematology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Reports Similar to the Gobal Immunohematology Maret 2025, By The Business Research Company:

Out-of-Home Advertising Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/out-of-home-advertising-global-market-report

Advertising Agencies Global Market Opportunities And Strategies To 2031: COVID-19 Impact And Recovery

https://www.thebusinessresearchcompany.com/report/advertising-agencies-market

Print Advertising Distribution Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/print-advertising-distribution-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the immunohematology market grown over the years?

The size of the immunohematology market has consistently inflated over the past years. With an assertion to expand from $2.46 billion in 2024 to $2.57 billion in 2025, it’s anticipated to mature at a compound annual growth rate (CAGR) of 4.6%. The historic period growth is influenced by progression in blood transfusion science, escalating instances of blood disorders, proliferation of blood banks, government strata directing towards blood safety, a rise in surgical procedures along with enhanced cognizance about risks linked to transfusion.

What Is the forecasted market size and growth rate for the immunohematology market?

Anticipated strong expansion is on the horizon for the immunohematology market size in the forthcoming years. It is slated to soar to “$3.24 billion by 2029, boasting a compound annual growth rate (CAGR) of 5.9%. This predicted boosting during the projected period can be contributed to factors like the rising need for point-of-care testing, the emergence of innovative blood-oriented products, broadening healthcare infrastructure, genetic examinations for blood compatibility, and the backing of regulations for blood safety. During the forecast period, key tendencies are likely to be automation, high-throughput systems, molecular methods of blood typing, techniques for antibody identification, patient blood management schemes, the incorporation of artificial intelligence in assessments, and the integration of telemedicine.

Get your immunohematology market report here!

https://www.thebusinessresearchcompany.com/report/immunohematology-global-market-report

What are the major factors driving growth in the immunohematology market?

An increase in the rate of hematological disorders is anticipated to fuel advancement in the immunohematology market. Hematological disorders, which are a varied set of conditions impacting the blood and blood constituents like red and white blood cells, platelets, and plasma, are on the rise. Immunohematology plays a crucial role in ensuring the safety and efficacy of blood transfusions by averting transfusion reactions triggered by incompatible blood groups or antibodies in the recipient’s blood. Techniques in immunohematology are also employed to detect and remedy diseases associated with the immune system that may have implications on the hematological system. As an example, Cancer Research UK, a research institution based in the UK, projects that the number of new leukemia cases due to hematological disorders in the UK is likely to escalate from an estimated 12,400 cases in 2023-2025 to about 14,500 cases in 2038-2040. The increasing incidence rate of hematological disorders, therefore, is prompting the expansion of the immunohematology market.

What key areas define the segmentation of the global immunohematology Market?

The immunohematology market covered in this report is segmented –

1) By Product: Analyzers And Systems, Reagents

2) By Technology: Biochips, Erythrocyte-Magnetized Technology (Met), Gel Cards, Microplates, Polymerase Chain Reaction (PCR)

3) By Disease: Blood-Related Diseases, HIV, Hepatitis

4) By Application: Pretransfusion Testing, Investigation Of Immune Hemolysis, Perinatal Testing, Blood Group Phenotyping, Leucocyte And Platelet Serology

5) By End User: Blood Banks, Diagnostic And Reference Laboratories, Hospitals, Academic And Research Institutes

Subsegments:

1) By Analyzers And Systems: Blood Typing Analyzers, Cross-Matching Analyzers, Gel Card Systems

2) By Reagents: Blood Grouping Reagents, Antisera, Control Serum

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10295&type=smp

What are the top market players propelling the growth of the immunohematology industry?

Major companies operating in the immunohematology market include Ortho Clinical Diagnostics Inc., Immunocor Inc., Abbott Laboratories, Siemens Healthineers AG, Grifols S.A., Beckman Coulter Inc., Thermo Fisher Scientific Inc., Becton Dickinson and Company, Merck Co. & KGaA, Bio-Rad Laboratories, Sysmex Corporation, Danaher Corporation, Biosystems S.A., Roche Holdings AG, Mindray Medical International Limited, F.Hoffmann La-Roche Ltd., Biotest AG, Cardinal Health Inc., Quotient Limited, DiaSorin S.p.A., Lorne Laboratories Ltd., Biokit S.A., Avox Technologies, Diagnostic Automation/Cortez Diagnostics Inc., Inno-train Diagnostik GmbH, Drucker Diagnostics Inc., Immundia Diagnostics Pvt. Ltd.

What are the key trends shaping the future of the immunohematology market?

Leading firms in the immunohematology market are strategizing to create unique diagnostic tools, such as soluble recombinant proteins, to counter the interference from the cancer treatment daratumumab. Soluble recombinant protein, generated with the help of recombinant DNA technology, retains its proper structure and function in a host cell or solution, making it valuable for research and therapeutic uses. For example, Grifols, S.A., a pharmaceutical company based in Spain, introduced the Grifols sCD38 solution in November 2023. This represents the first-ever soluble recombinant protein, designed to combat the interruption caused by cancer therapy daratumumab in essential blood transfusion compatibility checks. Aimed specifically at multiple myeloma patients, this pioneering solution prevents daratumumab from binding to CD38 proteins on red blood cells, thereby guaranteeing accurate pre-transfusion test results. By simplifying the procedure for screening, identifying, and cross-matching, Grifols sCD38 improves blood transfusion procedures and reduces the delay in providing critical transfusions.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10295

What regions are dominating the immunohematology market growth?

North America was the largest region in the immunohematology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global immunohematology market during the forecast period. The regions covered in the immunohematology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Similar Reports By The Business Research Company:

Out-of-Home Advertising Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/out-of-home-advertising-global-market-report

Advertising Agencies Global Market Opportunities And Strategies To 2031: COVID-19 Impact And Recovery

https://www.thebusinessresearchcompany.com/report/advertising-agencies-market

Print Advertising Distribution Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/print-advertising-distribution-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: